Nvidia and Eli Lilly unveiled a co-innovation AI Lab for drug discovery efforts. Nvidia announced a strategic collaboration ...

The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX).

The overall tally of drug approvals is down from 114 in 2024, with the EMA ascribing that record number to post-pandemic pent-up demand. However, the agency is expecting momentum to be maintained in ...

Travere Therapeutics FY25 sales surged on Filspari, but the FDA FSGS label decision was delayed to April. Click here to read ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Travere Therapeutics recently reported that the FDA has extended its review of the supplemental New Drug Application for ...

The latest health news highlights Vietnam's cigarette tax initiative, the FDA's review extension for Travere's kidney drug, ...

An extension was required to provide time to review additional data requested by the FDA to clarify sparsentan’s clinical benefit.

Travere Therapeutics shares fall after the FDA extends its review timeline for Filspari's sNDA in FSGS, pushing the decision ...

Much is riding on Travere Therapeutics’ bid to gain an expansion for Filspari to treat focal segmental glomerulosclerosis ...

WeRide ( WRD) +1.6% The company is making robotaxi booking effortless in China via Tencent's ( TCEHY) WeChat app. Residents ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.